Recruiting A Two Part Dose-escalation Safety and Efficacy Study of CID-103 in Adults With Active and Chronic Active Renal Allograft Antibody Mediated Rejection (ABMR). NCT07641426 Conditions Antibody Mediated Rejection Locations Beijing Friendship Hospital — Beijing, Beijing Municipality, China The First Affiliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology — Wuhan, Hubei, China The First Affiliated Hospital of Medical College of Xi'an Jiaotong University — Xi'an, Shaanxi, China View Trial Details
Completed Development and Validation of HistoMX, a Gene-Expression Platform for Molecular Interpretation of Kidney Allograft Biopsies NCT07700563 Conditions Antibody Mediated Rejection, BK Virus Nephropathy, Chronic Disease, +16 more Locations Not specified View Trial Details
Completed Quantitative Parameters of HLA-DQ Antibodies in Lung Transplantation NCT03474536 Conditions Antibody Mediated Rejection, Chronic Lung Allograft Dysfunction, Lung Transplantation Locations CHU Bordeaux — Bordeaux, France Hôpital Marie Lannelongue — Le Plessis-Robinson, France Hôpital Européen Georges Pompidou — Paris, France AP-HP Hôpital Bichat — Paris, France View more locations Show fewer locations Loading locations... View Trial Details
